X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Unichem Lab with Panacea Biotech - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

UNICHEM LAB vs PANACEA BIOTECH - Comparison Results

PANACEA BIOTECH 
   Change

Panacea Biotec is the second largest vaccine producer in India and has been ranked as the third largest biotechnology company in India (as per ABLE Survey 2006). While vaccines account for two-thirds of the company's overall revenues, the balance com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    UNICHEM LAB PANACEA BIOTECH UNICHEM LAB/
PANACEA BIOTECH
 
P/E (TTM) x 282.0 -7.0 - View Chart
P/BV x 0.6 2.3 28.5% View Chart
Dividend Yield % 2.6 0.0 -  

Financials

 UNICHEM LAB   PANACEA BIOTECH
EQUITY SHARE DATA
    UNICHEM LAB
Mar-18
PANACEA BIOTECH
Mar-14
UNICHEM LAB/
PANACEA BIOTECH
5-Yr Chart
Click to enlarge
High Rs382149 256.9%   
Low Rs23482 284.4%   
Sales per share (Unadj.) Rs116.384.1 138.2%  
Earnings per share (Unadj.) Rs-18.9-18.3 103.4%  
Cash flow per share (Unadj.) Rs-11.7-6.7 175.3%  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %1.60-  
Book value per share (Unadj.) Rs381.083.7 455.2%  
Shares outstanding (eoy) m70.3461.25 114.8%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.61.4 193.0%   
Avg P/E ratio x-16.3-6.3 258.1%  
P/CF ratio (eoy) x-26.2-17.2 152.2%  
Price / Book Value ratio x0.81.4 58.6%  
Dividend payout %-26.40-   
Avg Mkt Cap Rs m21,6687,074 306.3%   
No. of employees `0002.32.8 82.9%   
Total wages/salary Rs m2,0061,449 138.4%   
Avg. sales/employee Rs Th3,587.81,874.1 191.4%   
Avg. wages/employee Rs Th880.0527.0 167.0%   
Avg. net profit/employee Rs Th-583.7-407.7 143.2%   
INCOME DATA
Net Sales Rs m8,1805,154 158.7%  
Other income Rs m610100 611.3%   
Total revenues Rs m8,7905,254 167.3%   
Gross profit Rs m-1,320-766 172.3%  
Depreciation Rs m505711 71.0%   
Interest Rs m801,503 5.3%   
Profit before tax Rs m-1,295-2,881 45.0%   
Minority Interest Rs m011 0.0%   
Prior Period Items Rs m-2-6 38.6%   
Extraordinary Inc (Exp) Rs m01,771 0.0%   
Tax Rs m3317 198.9%   
Profit after tax Rs m-1,331-1,121 118.7%  
Gross profit margin %-16.1-14.9 108.5%  
Effective tax rate %-2.6-0.6 442.4%   
Net profit margin %-16.3-21.8 74.8%  
BALANCE SHEET DATA
Current assets Rs m23,3183,810 612.0%   
Current liabilities Rs m4,6358,365 55.4%   
Net working cap to sales %228.4-88.4 -258.4%  
Current ratio x5.00.5 1,104.5%  
Inventory Days Days122156 78.2%  
Debtors Days Days12167 180.7%  
Net fixed assets Rs m8,16314,480 56.4%   
Share capital Rs m14161 229.5%   
"Free" reserves Rs m26,660903 2,952.1%   
Net worth Rs m26,8015,127 522.7%   
Long term debt Rs m35,832 0.1%   
Total assets Rs m31,89019,433 164.1%  
Interest coverage x-15.2-0.9 1,655.3%   
Debt to equity ratio x01.1 0.0%  
Sales to assets ratio x0.30.3 96.7%   
Return on assets %-3.92.0 -199.7%  
Return on equity %-5.0-21.9 22.7%  
Return on capital %-4.53.6 -124.9%  
Exports to sales %024.5 0.0%   
Imports to sales %010.2 0.0%   
Exports (fob) Rs mNA1,264 0.0%   
Imports (cif) Rs mNA525 0.0%   
Fx inflow Rs m4,3561,539 283.0%   
Fx outflow Rs m0942 0.0%   
Net fx Rs m4,356597 729.5%   
CASH FLOW
From Operations Rs m-1,123599 -187.5%  
From Investments Rs m16,487-438 -3,764.9%  
From Financial Activity Rs m-8,811-303 2,911.9%  
Net Cashflow Rs m6,552-141 -4,636.9%  

Share Holding

Indian Promoters % 50.1 74.5 67.2%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 15.1 0.6 2,516.7%  
FIIs % 3.0 1.3 230.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 31.7 23.6 134.3%  
Shareholders   20,176 10,259 196.7%  
Pledged promoter(s) holding % 0.0 35.1 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare UNICHEM LAB With:   SUVEN LIFESCIENCES  SUN PHARMA  PIRAMAL ENTERPRISES  FDC LTD.  SHASUN PHARMA  

Compare UNICHEM LAB With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends Marginally Higher; Realty and IT Stocks Witness Buying(Closing)

Indian share markets witnessed volatility during closing hours and ended their day marginally higher. Gains were largely seen in the realty sector and IT sector.

Related Views on News

PANACEA BIOTECH Announces Quarterly Results (3QFY19); Net Profit Down 137.1% (Quarterly Result Update)

Feb 22, 2019 | Updated on Feb 22, 2019

For the quarter ended December 2018, PANACEA BIOTECH has posted a net profit of Rs 230 m (down 137.1% YoY). Sales on the other hand came in at Rs 1 bn (down 25.2% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

UNICHEM LAB Announces Quarterly Results (3QFY19); Net Profit Up 110.9% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, UNICHEM LAB has posted a net profit of Rs 63 m (up 110.9% YoY). Sales on the other hand came in at Rs 2 bn (up 53.8% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

PANACEA BIOTECH Announces Quarterly Results (2QFY19); Net Profit Down 1631.6% (Quarterly Result Update)

Nov 27, 2018 | Updated on Nov 27, 2018

For the quarter ended September 2018, PANACEA BIOTECH has posted a net profit of Rs 975 m (down 1631.6% YoY). Sales on the other hand came in at Rs 1 bn (down 22.3% YoY). Read on for a complete analysis of PANACEA BIOTECH's quarterly results.

UNICHEM LAB Announces Quarterly Results (2QFY19); Net Profit Down 61.4% (Quarterly Result Update)

Nov 5, 2018 | Updated on Nov 5, 2018

For the quarter ended September 2018, UNICHEM LAB has posted a net profit of Rs 177 m (down 61.4% YoY). Sales on the other hand came in at Rs 2 bn (down 42.6% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

UNICHEM LAB Announces Quarterly Results (1QFY19); Net Profit Down 1479.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, UNICHEM LAB has posted a net profit of Rs 207 m (down 1479.6% YoY). Sales on the other hand came in at Rs 2 bn (down 35.9% YoY). Read on for a complete analysis of UNICHEM LAB's quarterly results.

More Views on News

Most Popular

Are You Ready for the Big Nifty Move in the March Expiry?(Profit Hunter)

Mar 8, 2019

History suggests the Nifty could make a big move in March. Are you prepared to benefit from this opportunity?

5 Fundamentally Strong Stocks to Pick for Trading Today(Profit Hunter)

Mar 15, 2019

5 fundamentally strong stocks one could buy to trade in this market right now. Make sure you grab the chance this strongly rallying market offers.

Elections Don't Matter!(The Honest Truth)

Mar 13, 2019

Ajit Dayal shows us why from the point of view of the Indian economy, elections don't matter.

Two Growth Stocks that Doubled in a Little Over 12 Months!(The 5 Minute Wrapup)

Mar 13, 2019

The elements that fueled profit growth for these two companies led to a surge in their stock prices.

This is Why You Need to Buy Small Cap Stocks Now(The 5 Minute Wrapup)

Mar 15, 2019

Did you just miss the smallcap rally? Or is there still time to catch up? Read on for answers and more...

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

UNICHEM LAB SHARE PRICE


Mar 20, 2019 (Close)

TRACK UNICHEM LAB

  • Track your investment in UNICHEM LAB with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

UNICHEM LAB - FDC LTD. COMPARISON

COMPARE UNICHEM LAB WITH

MARKET STATS